Already partnering with the likes of Adaptimmune and Cellectis for immuno-oncology, MD Anderson has today added Germany’s Affimed to its growing list of I/O players. The biotech, which focuses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback